Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet
Anna Collado Gimbert(Vall d'Hebron Institut de Recerca), María del Mar Mañú‐Pereira(Vall d'Hebron Institut de Recerca), Tiziana Sanavia(University of Turin), Maria Paola Boaro(University of Padua), Sigrid van der Veen(Utrecht University), Elena Cela(Universidad Complutense de Madrid), Pablo Bartolucci(European Organisation for Rare Diseases), Petros Kountouris(Cyprus Institute of Neurology and Genetics), David Beneitez Pastor(Vall d'Hebron Hospital Universitari), Ana M. Ortuño(Vall d'Hebron Hospital Universitari), Gastone Castellani(University of Bologna), Federico Álvarez(Universidad Politécnica de Madrid), Renzo Manara(Azienda Ospedaliera di Padova), Piero Fariselli(University of Turin), Riccardo Biondi(University of Bologna), Bart J. Biemond(Amsterdam University Medical Centers), Marina Kleanthous(Cyprus Institute of Neurology and Genetics), Amira Idrizovic(Vall d'Hebron Institut de Recerca), Raffaella Colombatti(University of Padua), Anna Ruiz‐Llobet(Hospital Sant Joan de Déu Barcelona), Eduard J. van Beers(Utrecht University), M. de Montalembert(Inserm), Santiago Zazo(Universidad Politécnica de Madrid)
Cited by 11
Related Papers
CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory
|Mechanisms of Ageing and Development|1996|255
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
|Journal of Clinical Oncology|2023|109
Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology
|JCO Clinical Cancer Informatics|2023|86